undamentalytics Newsletter
Sign in

Opko Health, Inc. cash flow statement

In fiscal 2025, Opko Health, Inc.'s operations generated −$179m of cash; it spent $12.3m on capital projects, leaving free cash flow of −$191m. It returned $47.0m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−23−19−19−25−56−9016432−92−109−1733938−95−28−183−179−123
Depreciation and amortisation124101515429710297948579109105989290
Stock-based pay4775111526432822139141911111111
Capital spending012145111947281334322516251211
Free cash flow−24−19−20−27−60−9515313−139−137−18566−120−44−208−191−134
Free cash flow after stock pay−28−26−27−32−71−110127−29−167−159−199−3−7−138−56−220−202−145
Share buybacks——800————————00904747
Shares issued51010500132600937600—————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ALVO vs OPKEBS vs OPKOPK vs TVTX

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Opko Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Opko Health, Inc.